Facing the challenges in bio-pharmaceutical production: developments in ion exchange media to bring down cost of goods.

Preparative

Facing the challenges in bio-pharmaceutical production: developments in ion exchange media to bring down cost of goods.

22 Dec, 2009

Published over 16 years ago. See the latest and most current information on Preparative.

Noriko Shoji, Akiko Matsui, Masakatsu Omote, Naohiro Kuriyama, Britta Blödorn, Daniel Kune, Charles A. White
1 min read
Download

As the bio-pharmaceutical industry matures, terms like “cost of goods” are becoming more and more important. Up to now, strain optimisation for high productivity and upstream purification were the bottleneck for most bio-processes. However, with the progress made in recent years, titers in fermentation processes have increased significantly. Obviously, this increased volumetric productivity will help reducing the cost of goods, but it also has an impact on the downstream processing. Therefore, improved downstream processing media are required to process the increased product load in the same timeframe. Recently, new materials, based on fully synthetic polymer based matrices became available and show important advantages over traditional polysaccharide-derived media. In the following article the focus is on ion exchange chromatography (IEX) as an

important step in the biopharmaceutical process.

Latest Articles

Explore Our Other Sites

Labmate Online
Microneedle patch enables real-time drug monitoring
Explore more Arrow
Envirotech Online
New civil penalties and real-time monitoring raise the bar for water company compliance
Explore more Arrow
Pollution Solutions Online
Energy efficiency first: Why shipping must act now while low-GHG fuels scale
Explore more Arrow
Petro Online
Fifty years on, the EU reaffirms its commitment to Seveso-level industrial safety oversight
Explore more Arrow